Paul Fitzgerald, MD
Clinical Professor
Medicine
School of Medicine

Awards

Show all (2) Hide

• Haile T. Debas Academy of Medical Educators Excellence in Teaching Award, UCSF, 2019-2020
• Charlotte Baer Memorial Clinical Faculty Award, UCSF, 1989-1990

Education & Training

Show all (2) Hide

• Fellowship Endocrinology & Metabolism University of California, San Francisco 06/1979
• BA Pre-Medical, Psychology Dartmouth College 06/1968

Interests

Show all (7) Hide

• Editor
• Handbook of Clinical Endocrinology
• Appleton & Lange Pub
• Author
• Adrenal Medulla & Paraganglia Chapter in Basic and Clinical Endocrinology
• McGraw-Hill Pub
• Endocrine Disorders Chapter in Current Medical Diagnosis & Treatment (CMDT)

Websites

Show all (2) Hide

• @@Fitzgerald11111 on Twitter (twitter.com)
• Medical Practice (fitzgeraldmd.com)

Publications (21)

Top publication keywords:
Compassionate Use TrialsDose-Response Relationship, RadiationCushing SyndromePheochromocytomaProteinuriaAdrenocorticotropic HormoneAdrenal Gland NeoplasmsAntineoplastic AgentsPituitary NeoplasmsVirilismParaganglioma3-IodobenzylguanidineIodine RadioisotopesMetanephrineLeydig Cell Tumor

• Proteinuria in metastatic pheochromocytoma is associated with an increased risk of Acute Respiratory Distress Syndrome, spontaneously or after therapy with 131I-meta-iodobenzylguanidine (131I-MIBG).
  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2012 Porzig A, Matthay KK, Dubois S, Pampaloni M, Damon L, Hawkins R, Goldsby R, Hollinger F, Fitzgerald P
• Metastatic pheochromocytoma and paraganglioma: focus on therapeutics.
  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2012 Plouin PF, Fitzgerald P, Rich T, Ayala-Ramirez M, Perrier ND, Baudin E, Jimenez C
• Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma.
  Pediatric blood & cancer 2010 Quach A, Ji L, Mishra V, Sznewajs A, Veatch J, Huberty J, Franc B, Sposto R, Groshen S, Wei D, Fitzgerald P, Maris JM, Yanik G, Hawkins RA, Villablanca JG, Matthay KK
• Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).
  Annals of the New York Academy of Sciences 2006 Fitzgerald PA, Goldsby RE, Huberty JP, Price DC, Hawkins RA, Veatch JJ, Dela Cruz F, Jahan TM, Linker CA, Damon L, Matthay KK
• High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma.
  Cancer 2003 Rose B, Matthay KK, Price D, Huberty J, Klencke B, Norton JA, Fitzgerald PA
• Iatrogenic pheochromocytomatosis: a previously unreported result of laparoscopic adrenalectomy.
  Surgery 2001 Li ML, Fitzgerald PA, Price DC, Norton JA
• Normal female infants born of mothers with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
  The Journal of clinical endocrinology and metabolism 1999 Lo JC, Schwitzgebel VM, Tyrrell JB, Fitzgerald PA, Kaplan SL, Conte FA, Grumbach MM
• Occult virilizing ovarian tumours in postmenopausal women: problems in evaluation with reference to a case.
  Annals of the Academy of Medicine, Singapore 1998 Loh KC, Lo JC, Zaloudek CJ, Fitzgerald PA
• The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients.
  Journal of endocrinological investigation 1997 Loh KC, Fitzgerald PA, Matthay KK, Yeo PP, Price DC
• Diabetes insipidus from sarcoidosis confined to the posterior pituitary.
  European journal of endocrinology 1997 Loh KC, Green A, Dillon WP, Fitzgerald PA, Weidner N, Tyrrell JB
• Cushing's syndrome due to bilateral adrenal macronodular hyperplasia with undetectable ACTH: cell culture of adenoma cells on extracellular matrix.
  Hormone research 1988 Cheitlin RA, Westphal M, Cabrera CM, Fujii DK, Snyder J, Fitzgerald PA
• Euthyroid sick or 'hyperthyroid sick'?
  Hospital practice (Office ed.) 1987 Kerlikowske K, Fitzgerald PA, Hammami M
• Cushing's disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin.
  The Journal of clinical endocrinology and metabolism 1982 Fitzgerald PA, Aron DC, Findling JW, Brooks RM, Wilson CB, Forsham PH, Tyrrell JB
• Cushing's syndrome: problems in management.
  Endocrine reviews 1982 Aron DC, Findling JW, Fitzgerald PA, Forsham PH, Wilson CB, Tyrrell JB
• Fungal infections in Cushing's syndrome.
  Annals of internal medicine 1981 Findling JW, Tyrrell JB, Aron DC, Fitzgerald PA, Young CW, Sohnle PG
• Pituitary ACTH dependency of nodular adrenal hyperplasia in Cushing's syndrome. Report of two cases and review of the literature.
  The American journal of medicine 1981 Aron DC, Findling JW, Fitzgerald PA, Brooks RM, Fisher FE, Forsham PH, Tyrrell JB
• Silent pituitary apoplexy: subclinical infarction of an adrenocorticotropin-producing pituitary adenoma.
  The Journal of clinical endocrinology and metabolism 1981 Findling JW, Tyrrell JB, Aron DC, Fitzgerald PA, Wilson CB, Forsham PH
• Cushing's disease. Selective trans-sphenoidal resection of pituitary microadenomas.
  The New England journal of medicine 1978 Tyrrell JB, Brooks RM, Fitzgerald PA, Cofoid PB, Forsham PH, Wilson CB
• Human pituitary tumors secrete chromogranin-A.
  The Journal of clinical endocrinology and metabolism 1989 Deftos LJ, O'Connor DT, Wilson CB, Fitzgerald PA
• Cerebral salt wasting after pituitary exploration and biopsy: case report.
  Neurosurgery 1986 Andrews BT, Fitzgerald PA, Tyrell JB, Wilson CB
• Cushing's disease revisited.
  American journal of surgery 1979 Wilson CB, Tyrrell JB, Fitzgerald P